AZITRA, INC. ADVANCES ATR-04 PHASE 1/2 CLINICAL TRIAL TO COHORT 2 FOLLOWING SAFETY REVIEW COMMITTEE CLEARANCE

Reuters · 2d ago

Please log in to view news